Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial

J. Scott Roberts, Melissa Barber, Tamsen M. Brown, L. Adrienne Cupples, Lindsay A. Farrer, Susan A. LaRusse, Stephen G. Post, Kimberly A. Quaid, Lisa D. Ravdin, Norman R. Relkin, A. Dessa Sadovnick, Peter J. Whitehouse, John L. Woodard, Robert C. Green

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Purpose: Alzheimer's disease, for which one form of the apolipoprotein E (APOE) genotype is a risk factor, provides a paradigm in which to examine response to susceptibility testing for common, complex diseases. This study's main purposes were to estimate interest in such testing and to examine demographic predictors of study participation. Methods: In this 3-site, randomized clinical trial (RCT), the intervention was a risk assessment program wherein genetic counselors educated adult children of AD patients about lifetime risk of disease based on their gender, family history, and APOE genotype. Two groups of participants were followed from initial contact to RCT enrollment: those who were systematically contacted through research registries, and those who were self-referred. Results: Of 196 systematically contacted participants, 47, or 24%, progressed from initial contact to RCT enrollment. These participants were more likely to be below age 60 (adjusted OR = 3.83, P < 0.01) and college educated (adjusted OR = 3.48, P < 0.01). Of 179 self-referred participants, 115, or 64%, progressed from initial contact to RCT enrollment. Most self-referred participants had a college education and were female (79%). Conclusions: In the first RCT to examine genetic susceptibility testing for AD, uptake rates were sufficiently high to merit concern that future test demand may strain available education and counseling resources. Findings suggest that susceptibility testing for AD may be of particular interest to women, college educated persons, and persons below age 60.

Original languageEnglish (US)
Pages (from-to)197-203
Number of pages7
JournalGenetics in Medicine
Volume6
Issue number4
DOIs
StatePublished - Jul 1 2004

Fingerprint

Genetic Testing
Genetic Predisposition to Disease
Alzheimer Disease
Randomized Controlled Trials
Apolipoproteins E
Genotype
Education
Adult Children
Registries
Counseling
Demography
Research

Keywords

  • Alzheimer's disease
  • APOE
  • Genetic counseling
  • Genetic testing
  • Test uptake

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Roberts, J. S., Barber, M., Brown, T. M., Cupples, L. A., Farrer, L. A., LaRusse, S. A., ... Green, R. C. (2004). Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genetics in Medicine, 6(4), 197-203. https://doi.org/10.1097/01.GIM.0000132688.55591.77

Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. / Roberts, J. Scott; Barber, Melissa; Brown, Tamsen M.; Cupples, L. Adrienne; Farrer, Lindsay A.; LaRusse, Susan A.; Post, Stephen G.; Quaid, Kimberly A.; Ravdin, Lisa D.; Relkin, Norman R.; Sadovnick, A. Dessa; Whitehouse, Peter J.; Woodard, John L.; Green, Robert C.

In: Genetics in Medicine, Vol. 6, No. 4, 01.07.2004, p. 197-203.

Research output: Contribution to journalArticle

Roberts, JS, Barber, M, Brown, TM, Cupples, LA, Farrer, LA, LaRusse, SA, Post, SG, Quaid, KA, Ravdin, LD, Relkin, NR, Sadovnick, AD, Whitehouse, PJ, Woodard, JL & Green, RC 2004, 'Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial', Genetics in Medicine, vol. 6, no. 4, pp. 197-203. https://doi.org/10.1097/01.GIM.0000132688.55591.77
Roberts, J. Scott ; Barber, Melissa ; Brown, Tamsen M. ; Cupples, L. Adrienne ; Farrer, Lindsay A. ; LaRusse, Susan A. ; Post, Stephen G. ; Quaid, Kimberly A. ; Ravdin, Lisa D. ; Relkin, Norman R. ; Sadovnick, A. Dessa ; Whitehouse, Peter J. ; Woodard, John L. ; Green, Robert C. / Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. In: Genetics in Medicine. 2004 ; Vol. 6, No. 4. pp. 197-203.
@article{3c88c46f08ff4d6396e6bc2af89973cf,
title = "Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial",
abstract = "Purpose: Alzheimer's disease, for which one form of the apolipoprotein E (APOE) genotype is a risk factor, provides a paradigm in which to examine response to susceptibility testing for common, complex diseases. This study's main purposes were to estimate interest in such testing and to examine demographic predictors of study participation. Methods: In this 3-site, randomized clinical trial (RCT), the intervention was a risk assessment program wherein genetic counselors educated adult children of AD patients about lifetime risk of disease based on their gender, family history, and APOE genotype. Two groups of participants were followed from initial contact to RCT enrollment: those who were systematically contacted through research registries, and those who were self-referred. Results: Of 196 systematically contacted participants, 47, or 24{\%}, progressed from initial contact to RCT enrollment. These participants were more likely to be below age 60 (adjusted OR = 3.83, P < 0.01) and college educated (adjusted OR = 3.48, P < 0.01). Of 179 self-referred participants, 115, or 64{\%}, progressed from initial contact to RCT enrollment. Most self-referred participants had a college education and were female (79{\%}). Conclusions: In the first RCT to examine genetic susceptibility testing for AD, uptake rates were sufficiently high to merit concern that future test demand may strain available education and counseling resources. Findings suggest that susceptibility testing for AD may be of particular interest to women, college educated persons, and persons below age 60.",
keywords = "Alzheimer's disease, APOE, Genetic counseling, Genetic testing, Test uptake",
author = "Roberts, {J. Scott} and Melissa Barber and Brown, {Tamsen M.} and Cupples, {L. Adrienne} and Farrer, {Lindsay A.} and LaRusse, {Susan A.} and Post, {Stephen G.} and Quaid, {Kimberly A.} and Ravdin, {Lisa D.} and Relkin, {Norman R.} and Sadovnick, {A. Dessa} and Whitehouse, {Peter J.} and Woodard, {John L.} and Green, {Robert C.}",
year = "2004",
month = "7",
day = "1",
doi = "10.1097/01.GIM.0000132688.55591.77",
language = "English (US)",
volume = "6",
pages = "197--203",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial

AU - Roberts, J. Scott

AU - Barber, Melissa

AU - Brown, Tamsen M.

AU - Cupples, L. Adrienne

AU - Farrer, Lindsay A.

AU - LaRusse, Susan A.

AU - Post, Stephen G.

AU - Quaid, Kimberly A.

AU - Ravdin, Lisa D.

AU - Relkin, Norman R.

AU - Sadovnick, A. Dessa

AU - Whitehouse, Peter J.

AU - Woodard, John L.

AU - Green, Robert C.

PY - 2004/7/1

Y1 - 2004/7/1

N2 - Purpose: Alzheimer's disease, for which one form of the apolipoprotein E (APOE) genotype is a risk factor, provides a paradigm in which to examine response to susceptibility testing for common, complex diseases. This study's main purposes were to estimate interest in such testing and to examine demographic predictors of study participation. Methods: In this 3-site, randomized clinical trial (RCT), the intervention was a risk assessment program wherein genetic counselors educated adult children of AD patients about lifetime risk of disease based on their gender, family history, and APOE genotype. Two groups of participants were followed from initial contact to RCT enrollment: those who were systematically contacted through research registries, and those who were self-referred. Results: Of 196 systematically contacted participants, 47, or 24%, progressed from initial contact to RCT enrollment. These participants were more likely to be below age 60 (adjusted OR = 3.83, P < 0.01) and college educated (adjusted OR = 3.48, P < 0.01). Of 179 self-referred participants, 115, or 64%, progressed from initial contact to RCT enrollment. Most self-referred participants had a college education and were female (79%). Conclusions: In the first RCT to examine genetic susceptibility testing for AD, uptake rates were sufficiently high to merit concern that future test demand may strain available education and counseling resources. Findings suggest that susceptibility testing for AD may be of particular interest to women, college educated persons, and persons below age 60.

AB - Purpose: Alzheimer's disease, for which one form of the apolipoprotein E (APOE) genotype is a risk factor, provides a paradigm in which to examine response to susceptibility testing for common, complex diseases. This study's main purposes were to estimate interest in such testing and to examine demographic predictors of study participation. Methods: In this 3-site, randomized clinical trial (RCT), the intervention was a risk assessment program wherein genetic counselors educated adult children of AD patients about lifetime risk of disease based on their gender, family history, and APOE genotype. Two groups of participants were followed from initial contact to RCT enrollment: those who were systematically contacted through research registries, and those who were self-referred. Results: Of 196 systematically contacted participants, 47, or 24%, progressed from initial contact to RCT enrollment. These participants were more likely to be below age 60 (adjusted OR = 3.83, P < 0.01) and college educated (adjusted OR = 3.48, P < 0.01). Of 179 self-referred participants, 115, or 64%, progressed from initial contact to RCT enrollment. Most self-referred participants had a college education and were female (79%). Conclusions: In the first RCT to examine genetic susceptibility testing for AD, uptake rates were sufficiently high to merit concern that future test demand may strain available education and counseling resources. Findings suggest that susceptibility testing for AD may be of particular interest to women, college educated persons, and persons below age 60.

KW - Alzheimer's disease

KW - APOE

KW - Genetic counseling

KW - Genetic testing

KW - Test uptake

UR - http://www.scopus.com/inward/record.url?scp=3442890962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3442890962&partnerID=8YFLogxK

U2 - 10.1097/01.GIM.0000132688.55591.77

DO - 10.1097/01.GIM.0000132688.55591.77

M3 - Article

C2 - 15266207

AN - SCOPUS:3442890962

VL - 6

SP - 197

EP - 203

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 4

ER -